- Sort by:
- Browse by:
- Permission not
granted for presentation
Invited Speaker
Crystal L. Mackall
National Cancer Inst., Bethesda, MD, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Raymond N. DuBois
Arizona State Univ., Tempe, AZ, United States
- Free
- audio + slides
- Some slides withheld
Invited Speaker
Kimberly Stegmaier
Dana-Farber Cancer Inst., Boston, MA, United States
- Permission not
granted for presentation
Invited Speaker
David M. Sabatini
MIT Whitehead Inst. for Biomed. Research, Cambridge, MA, United States
- Permission not
granted for presentation
Invited Speaker
Adolfo Ferrando
Columbia Univ., New York, NY, United States
- Permission not
granted for presentation
Invited Speaker
Perry D. Nisen
GlaxoSmithKline, King of Prussia, PA, United States
- Free
- audio + slides
- Some slides withheld
Invited Speaker
Melissa A Troester
UNC Lineberger Comp. Cancer Ctr., Chapel Hill, NC, United States
- Permission not
granted for presentation
Invited Speaker
Leisa Johnson
Genentech, Inc., South San Francisco, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Extent of subclonal diversification in primary and metastatic breast cancer
Peter J. Campbell
Wellcome Trust Sanger Inst., Cambridge, United Kingdom
- Permission not
granted for presentation
The breast epithelial hierarchy and its implications for tumor heterogeneity
Jane E. Visvader
Walter & Eliza Hall Inst. of Med. Research, Parkville, Australia
- Free
- slides video
- audio + slides
- All slides included
Clonal Heterogeneity in Acute Myeloid Leukemia
Timothy J. Ley
Washington Univ. School of Medicine, St. Louis, MO, United States
- Permission not
granted for presentation
Where Lies the Heterogeneity in GBM
Luis F. Parada
UT Southwestern Medical Ctr., Dallas, TX, United States
- Permission not
granted for presentation
Cancer immunoediting: applying mechanistic insights to cancer immunotherapy
Robert D Schreiber
Washington Univ. School of Medicine, St. Louis, MO, United States
- Permission not
granted for presentation
New approaches to old targets: HER3 and KRAS
Nathanael Gray
Dana-Farber Cancer Inst., Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Chemical genetics on the frontline of drug target discovery: Pathways, targets, and technology
John Tallarico
Novartis Insts. For BioMedical Research, Cambridge, MA, United States
- Permission not
granted for presentation
Chemo proteomic mapping of signaling pathways and drug action in cancer cells
Benjamin F Cravatt
The Scripps Research Inst., La Jolla, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Identification of a new druggable pocket on K-Ras
Kevan M Shokat
University of California, San Francisco, San Francisco, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Genetic Variation and Breast Cancer Risk
David J. Hunter
Harvard School of Public Health, Boston, MA, United States
- Permission not
granted for presentation
Genetic predisposition to prostate cancer (PrCa) and its clinical application
Rosalind A. Eeles
Inst. of Cancer Research, Sutton, United Kingdom
- Free
- slides video
- audio + slides
- All slides included
Consortium efforts to discover ovarian cancer risk variants
Thomas A. Sellers
H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL, United States
- Free
- audio + slides
- Some slides withheld
Genetic risk factors for colorectal cancer - Search for common and rare variants, gene-environment interactions and translation towards risk prediction
Ulrike Peters
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
- Permission not
granted for presentation
Racial disparities and genetics of prostate cancer
Michael B. Cook
National Cancer Institute, Rockville, MD, United States
- Free
- slides video
- audio + slides
- All slides included
Multilevel Genomic Models of Cancer Disparities
Timothy R. Rebbeck
Univ. of Pennsylvania School of Medicine, Philadelphia, PA, United States
- Permission not
granted for presentation
Tumor elicited inflammation and malignant progression in colorectal cancer
Michael Karin
UCSD, La Jolla, CA, United States
- Permission not
granted for presentation
The role of immature myeloid cells in gastrointestinal cancer
Timothy C. Wang
Columbia Univ. Medical Ctr., New York, NY, United States